Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence.
Lever E, Colquhoun M, Flora K, El-Ghazali S, Baslas R, Suleman Y, Wieckowski A, Farah Z, Hamdulay S, Isaacs A, Mukherjee J, Pazos F, Penn H, Machado PM.
Lever E, et al.
Rheumatol Adv Pract. 2022 Mar 10;6(1):rkac009. doi: 10.1093/rap/rkac009. eCollection 2022.
Rheumatol Adv Pract. 2022.
PMID: 35350718
Free PMC article.
No abstract available.